Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by No Interventin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Unknown2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06521515UnknownPrimary

Lung Ultrasound Morphology Patterns Predict Weaning Outcomes

NCT04220437Unknown

Identification of Neoatherosclerosis in ISR Patients Based on Artifical Intelligence

NCT04414085CompletedPrimary

The Clinical Significance of Biochemical 11 Deoxycortisol Levels

Showing all 3 trials

Research Network

Common Treatments

  • No Interventin1
  • Lung Ultrasound Morphology Patterns1

Active Sponsors

  • Assaf Harofeh MC1
  • Shanghai Zhongshan Hospital1
  • Chinese PLA General Hospital1

Top Investigators

Related Conditions

  • Neoatherosclerosis1
  • Instent Restenosis1

Activity Timeline